Introducing the new Spruson & Ferguson brand
Today, Spruson & Ferguson is proud to unveil our new brand. Our new brand builds on our position as a market leader in intellectual property services, and defines what will...
Today, Spruson & Ferguson is proud to unveil our new brand. Our new brand builds on our position as a...
Read More
Pharmaceutical patent term extension in Australia
This article was first published in the 2023 Pharmaceutical Patent Review. Patent term extensions (PTEs) can be of great commercial importance, and in recent years have become of particular interest...
This article was first published in the 2023 Pharmaceutical Patent Review. Patent term extensions (PTEs) can be of great commercial...
Read More
Pharmaceutical patent term extension update: the Commissioner appeals the Ono decision and the Australian Patent Office releases a practice update
The Australian Patent Commissioner has appealed the Federal Court decision of Ono Pharmaceutical Co, Ltd v Commissioner of Patents FCA 643 (“Ono”) relating to pharmaceutical patent term extensions...
The Australian Patent Commissioner has appealed the Federal Court decision of Ono Pharmaceutical Co, Ltd v Commissioner of Patents...
Read More
The Evolving Patentability of Genetic Material in Australia post-Myriad
A number of decisions by the Australian Patent Office following the 2015 “Myriad” decision have provided further clarity in regard to what genetic material may be patentable under Australian...
A number of decisions by the Australian Patent Office following the 2015 “Myriad” decision have provided further clarity in...
Read More

Contact our Expert Team

Contact Us
Contact Us